Retrying To Get Rejected Obesity Drugs FDA Approved
March 25, 2011 |
Dr. Kane | tagged
Diet Doctor NYC,
Obesity Drugs,
Weight Loss,
Weight Loss Doctor NYC,
Weight Loss Drugs,
diet doctor,
medical weight loss,
medical weight loss NYC,
weight loss NYC,
weight loss doctor | in
In the News,
Medical Weight Loss
“Obesity experts” met with FDA representatives on March 22 in a seeming attempt to push the passage of three new medications that were recently rejected by the FDA Contrave, QNexa and Lorquess seeking answers for what type of supplemental information would be required to get these drugs FDA approved.
Here is a brief overview of the three meds in question:
Contrave is a combination of two existing medications (bupropion – an anti-depressant and naltrexone). 64.9 percent of the patients who took Contrave lost at least 5 percent of their body weight after 56 weeks, and 39.4 percent lost at least 10 percent of their body weight in pre-release studies. Bupropion is a metabolite of diethylpropion (more commonly known as tenuate) and as such carries some weight loss potential. In fact, there is a dose-dependent weight loss with bupropion ranging from 5-10% on average. Presumably, the naltrexone was designed to help with cravings, although it seems as if the results really weren’t much of an improvement. While this was the closest of the drugs to being passed, it was put on hold pending further cardiac outcomes. Frankly, I can’t see what the big deal is with this drug and why it represents any improvement over bupropion alone.
Qnexa is the most intriguing of the three of these medications as it combines two medications that can have relatively potent weight loss effects. Phentermine is that last remaining FDA approved weight loss drug with potential for dramatic weight loss. It is a stimulant that revs up metabolism and decreases appetite. As a stimulant, though, the side effect profile can include increased heart rate, increased blood pressure, anxiety, insomnia and dry mouth. Some people are willing to tolerate these side effects to get pounds off. My biggest concern with it, is that a percentage of people who take it quickly regain the weight they lost. Topiramate is an anti-seizure drug that is also quite effective in treating migraine headaches. It was found at higher doses to produce fairly significant weight loss. The side effect profile on this drug, though, is not clean either, including fatigue, memory loss and word-finding difficulties, peripheral nerve issues and in less common, but serious cases, vision problems involving glaucoma. The potential for side effects, not questions of efficacy blocked this combo pill from coming out on the market.
Lorquess is the only new compound that was up for review and also got rejected for potential ill-effects (a number of heart-valve problems and even tumors in rat-brains). It’s mechanism of action is the targeting of appetite controlling serotonin receptors in the brain, similar to Meridia (sibutramine) which was removed from the market recently for concerns over cardiac risks. The effects of Lorquess would likely not be as dramatic as Qnexa, although the rejection was over safety, not efficacy.
One of the problems I have always had with obesity drug studies is that they determine efficacy of the drug by percentage of weight loss usually with a cutoff of 5% total body weight loss and sometimes comparing to 10%. For most obese patients, though, this is a drop in the bucket, particularly if the weight loss is medically induced. A good suggestion proposed by Dr. Louis Aronne, one of the representatives meeting with the panel and the former president of NAASO/The Obesity Society, is looking at obesity-related disease modification rather than just weight. If someone could improve their obstructive sleep apnea , diabetes management or cardiovascular risk through weight loss, does it really matter what percentage of body weight is involved? This is probably a good metric for many drug studies. It is quick and easy to judge how much a blood pressure is lowered by an agent in days, weeks or months, but blood pressure leads to serious complications – heart attack, stroke, kidney disease, etc. Long term outcomes are why we modify the modifiable (such as blood pressure, blood sugar or in this case excess weight). I just don’t think these drugs are potent or new enough to warrant necessarily passing them through.
I will write more soon on my take on weight-loss drugs, but my experience to date is that very few people who need to lose a significant amount of weight get and stay at their healthy target via weight-loss medications. Proper diet, increased physical activity and an eye towards calorie balance are what is called for in most cases. The tougher question for physicians is not what medication to prescribe, but how to help people adapt their lifestyle accordingly.
Image courtesy of alainu on flickr




